ArticleFrontiers in pharmacology2024

Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.

Xianglin Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.